Although the presenilin (PS) genes have been linked to familial Alzheimer's disease (FAD), little is known about the physiological functions of the PS or the molecules with which they interact. Moreover, even less is known concerning the effects of FAD- linked PS mutations on functions of PS or their impact on amyloidogenesis or the cellular abnormalities characteristic of AD. PS1/PS2 are integral transmembrane proteins homologous to sel-12, a C. elegans protein involved in an intracellular signaling pathway mediated by members of the Notch/lin-12 family of receptors, which play important roles in determining cell fate. Results from preliminary studies suggest that PS mutations may influence APP metabolism to promote the production of highly amyloidgenic A beta molecules. This project is designed to clarify the roles of PD in development and aging and the influence of PS on APP processing, takes advantages of our expertise in gene targeting methods. PS genes will be ablated, and will examine in detail the phenotypes of the PS1/PS2 targeted hetero-and homozygotes at various stages of development and maturity using a variety of ICC, histological, and stereological methods. It is conceivable that the highly homologous PS proteins may exhibit functional redundancies, and mice null for PS1/PS2 may be phenotypically normal. If so, we will breed mice with deleted PS1/PS2 alleles to generate progeny that are null for both genes and examine the consequences of the double- null state. Because recent work in C. elegans indicates that mutations in sel-12 suppress gain-of-function mutations in the intracellular receptor lin-12, suggesting that sel-12 may be involved in intracellular signalling pathways dependent on activation of lin-12 receptor, we want to identify molecules that interact directly with PS. The yeast two hybrid system will be used to identify proteins interacting with PS1. In our laboratory, this strategy has been useful in identifying HAP-1, which interacts with huntingin. In concert, these efforts will provide new information concerning the roles of PS in neural developing and identify proteins interacting with wt mutant PS.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
1P01AG014248-01
Application #
6234613
Study Section
Project Start
1997-03-12
Project End
1998-02-28
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Savonenko, Alena V; Melnikova, Tatiana; Hiatt, Andrew et al. (2012) Alzheimer's therapeutics: translation of preclinical science to clinical drug development. Neuropsychopharmacology 37:261-77
Zhang, Xulun; Garbett, Krassimira; Veeraraghavalu, Karthikeyan et al. (2012) A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J Neurosci 32:8633-48
Jankowsky, Joanna L; Younkin, Linda H; Gonzales, Victoria et al. (2007) Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice. J Biol Chem 282:22707-20
Jankowsky, Joanna L; Fadale, Daniel J; Anderson, Jeffrey et al. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13:159-70
Jankowsky, Joanna L; Slunt, Hilda H; Gonzales, Victoria et al. (2004) APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging 25:885-92
Xu, Guilian; Gonzales, Victoria; Borchelt, David R (2002) Abeta deposition does not cause the aggregation of endogenous tau in transgenic mice. Alzheimer Dis Assoc Disord 16:196-201
Ikeuchi, Takesh; Sisodia, Sangram S (2002) Cell-free generation of the notch1 intracellular domain (NICD) and APP-CTfgamma: evidence for distinct intramembranous ""gamma-secretase"" activities. Neuromolecular Med 1:43-54
Lee, Michael K; Stirling, Wanda; Xu, Yanqun et al. (2002) Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A 99:8968-73
Wong, Philip C; Cai, Huaibin; Borchelt, David R et al. (2002) Genetically engineered mouse models of neurodegenerative diseases. Nat Neurosci 5:633-9
Xu, Guilian; Gonzales, Victoria; Borchelt, David R (2002) Rapid detection of protein aggregates in the brains of Alzheimer patients and transgenic mouse models of amyloidosis. Alzheimer Dis Assoc Disord 16:191-5

Showing the most recent 10 out of 37 publications